medic
hypothes
journal
homepag
wwwelseviercomlocatemehi
editor
outbreak
novel
coronaviru
diseas
center
hubei
provinc
peopl
republ
china
spread
mani
countri
world
thirti
januari
declar
global
health
emerg
world
tyrel
byno
first
describ
cultiv
coronavirus
envelop
posit
singlestrand
larg
rna
virus
infect
human
anim
median
incub
period
infect
three
day
rang
day
clinic
manifest
diseas
consist
fever
dri
cough
nasal
congest
fatigu
headach
diseas
progress
dyspnoea
pneumonia
report
describ
gastrointestin
fulmin
myocard
infect
lung
alveolar
epitheli
cell
use
receptormedi
endocytosi
coronaviru
spike
protein
contain
ligand
bind
domain
angiotensinconvert
enzym
ii
viru
enteri
first
line
defenc
mechan
innat
recognit
invad
viru
pathogen
associ
molecular
pattern
pamp
via
endosom
rna
receptor
cytosol
rna
sensor
recognit
lead
activ
downstream
signal
cascad
induc
express
type
ifn
proinflammatori
cytokin
activ
jakstat
pathway
initi
transcript
ifn
type
also
increas
number
neutrophil
decreas
number
lymphocyt
lymphopenia
second
line
defens
mechan
adapt
elev
inflammatori
marker
like
creactiv
protein
proinflammatori
cytokin
like
gcsf
correl
diseas
sever
death
viru
directli
infect
macrophag
cell
macrophag
present
viral
antigen
peptid
cell
differenti
follicular
helper
cell
fh
cell
activ
cell
cell
antibodi
secret
cell
asc
asc
ico
ctfh
cell
recruit
differ
immun
cell
popul
asc
tfh
cell
activ
cell
igm
igg
antibodi
patient
blood
viral
antigen
lead
stimul
antibodi
format
igm
acut
phase
igg
type
chronic
phase
facilit
viral
entri
fusion
infect
cell
uptak
virusigg
complex
via
fc
famili
receptor
later
viral
fusion
antigen
present
cell
like
macrophag
b
cell
monocyt
via
fcr
famili
vascular
endothelium
neonat
fc
receptor
nfcr
instead
antibodi
induc
viral
agglutin
known
antibodi
depend
enhanc
ade
agab
immun
complex
deposit
lung
also
end
complement
activ
classic
pathway
complement
membran
attack
complex
mac
end
format
lead
vasoact
amin
releas
mast
cell
basophil
platelet
aggreg
lead
microthrombu
format
block
coronari
blood
vessel
heart
also
lead
neutophil
infiltr
aggreg
site
infect
alveoli
lead
sever
tissu
damag
main
cell
type
iii
hypersensit
reaction
patient
show
increas
neutrophil
number
immun
mechan
rheumatoid
arthriti
thu
function
complement
activ
instead
viral
clearanc
antigen
present
phagocytosi
act
rout
viral
infect
addit
immun
complex
anti
protein
cov
immun
complex
lead
increas
cytokin
releas
like
lung
macrophag
known
cytokin
storm
syndrom
rheumatoid
arthriti
known
cytokin
soup
trail
use
monoclon
antibodi
use
treatment
rheumatoid
arthriti
like
tocilizumab
monoclon
antibodi
none
none
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
